Article
Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factors.
Journal of the National Cancer Institute - 2 May 1990
Bookman M A, Lardelli P, Jaffe E S, Duffey P L, Longo D L
Abstract excerpt
Diffuse intermediately differentiated lymphocytic lymphoma (IDL) is a rare (approximately 2.5%) histologic subtype of malignant lymphoma. We have reviewed the morphologic, immunophenotypic, and clinical features of this disease in 23 patients treated at the National Cancer Institute in the 25-yea...
Topics
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Combined Modality Therapy
- Cyclophosphamide
- Female
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell
- Male
- Middle Aged
- Phenotype
- Prednisone
- Prognosis
- Prospective Studies
- Retrospective Studies
- Survival Rate
- Vincristine
- Whole-Body Irradiation
